Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice

The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal in Dutch general prac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:NPJ Prim Care Respir Med
Hlavní autoři: van den Bemt, Lisette, van den Nieuwenhof, Lotte, Rutjes, Anne, van der Meer, Victor, Stege, Gerben, Wensing, Michel, Teichert, Martina, Schermer, Tjard
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547069/
https://ncbi.nlm.nih.gov/pubmed/33037200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00198-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky